The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese

Thrombosis Research

Volumn 97, Issue 3, 2000, Pages 89-94

  Lin, Jen Shiou ^a   Shen, Ming Ching ^a   Tsai, Woei ^a   Lin, Bodo ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese; Deep vein thrombosis; Homocysteine; Methylenetetrahydrofolate reductase; Risk factor; Venous thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ARTICLE; CHINESE; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; PREVALENCE; RISK FACTORS; SEX FACTORS; TAIWAN; THROMBOPHILIA; VEINS; VENOUS THROMBOSIS;

EID: 0033972749     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00160-7     Document Type: Article

References (22)

1. Shen M.C., Lin J.S., Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res. 87:1997;377-385.
2. Ko Y.L., Hsu T.S., Wu S.M., Chen W.J., Cheng N.J., Kuo C.T., Chiang C.W., Lee Y.S. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese. An analysis of 618 individuals Hum Genet. 98:1996;176-177.
3. Liu H.W., Kwong Y.L., Bourke C., Lam C.K., Lie A.K.W., Wei D., Chan L.C. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost. 71:1994;416-419.
4. Lin J.S., Shen M.C., Tsay W. The mutation at position 20210 in the 3′-untranslated region of the prothrombin gene is extremely rare in Taiwanese Chinese patients with venous thrombophilia (letter). Thromb Haemost. 80:1998;343.
5. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia. An independent risk factor for vascular disease N Engl J Med. 324:1991;1149-1155.
6. Verhoef P., Hennekens C.H., Malinow R., Kok F.J., Willet W.C., Stampfer M.J. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke. 25:1994;1924-1930.
7. Boushey C.J., Bereford S.S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
8. Den Heijer M., Koster T., Blom H.J., Bos G.M.J., Briet E., Reitsma P.H., Vandebroucke J.P., Rosendaal F.R. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med. 334:1996;759-762.
9. Den Heijer M., Blom H.J., Gerris W.B.J., Rosendaal F.R., Haak H.L., Wijermans P.W., Bos G.M.J. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet. 345:1995;882-885.
10. Simioni P., Prandoni P., Burlina A., Tormene D., Sardella C., Ferrari V., Benedetti L., Girolami A. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. Thromb Haemost. 76:1996;883-886.
11. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.H.J., den Heijer M., Kluijtmans L.A.J., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease. A common mutation in methylenetetrahydrofolate reductase Nat Genet. 10:1995;111-113.
12. Kang S.S., Wong P.W.K., Susmano A., Sora J., Norusis M., Ruggie N. Thermolabile methylenetetrahydrofolate reductase. An inherited risk factor for coronary disease Am J Hum Genet. 48:1991;536-545.
13. Motulsky A.G. Nutritional ecogenetics. Homocysteine-related arteriosclerotic vascular disease, neutral tube defect, and folic acid Am J Hum Genet. 58:1996;17-20.
14. Schwartz S.M., Siscovick D.S., Malinow M.R., Rosendaal F.R., Beverly R.K., Hess D.L., Psaty B.M., Longstreth W.T. Jr., Koepsell T.D., Raghunathan T.E., Reitsma P.H. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation. 96:1997;412-417.
15. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., Malinow M.R., Willet W.C., Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation. 94:1996;2410-2416.
16. Christensen B., Frosst P., Lussier-Cacan S., Selhub J., Goyette P., Rosenblatt D.S., Genest J. Jr., Rozen R. Correlation of a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 17:1997;569-573.
17. Jacques P.F., Bostom A.G., William R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
18. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., Costa F.F. The mutation Ala677->Val in the methylenetetrahydrofolate reductase gene. A risk factor for arterial disease and venous thrombosis Thromb Haemost. 77:1997;818-821.
19. Tosetto A., Missiaglia E., Frezzato M., Rodeghiero F. The VITA project. C677T mutation in the methylenetetrahydrofolate reductase gene and risk of venous thromboembolism Br J Haematol. 97:1997;804-806.
20. Morita H., Taguchi J., Kurihara H., Kitaoka M., Kaneda H., Kurihara Y., Maemura K., Shindo T., Minamino T., Ohno M., Yamaoki K., Ogasawara K., Aizawa T., Suzuki S., Yazaki Y. Genetic polymorphism of 5, 10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 95:1997;2032-2036.
21. Pepe G., Camacho Vanegagas O., Giusti B., Brunelli T., Marcucci R., Attanasio M., Rickards O., De Stefano G.F., Prisco D., Gensini G.F., Abbate R. Heterogeneity in world distribution of the thermolabile C677T mutation in 5, 10-methylenetetrahydrofolate reductase. Am J Hum Genet. 63:1998;917-920. [letter].
22. Morita H., Kurihara H., Tsubaki S., Sugiyama T., Hamada C., Kurihara Y., Shindo T., Oh-hashi Y., Kitamura K., Yazaki Y. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol. 18:1998;1465-1469.